Skip to content
10-Q

Quarterly Report

VICAPSYS LIFE SCIENCES, INC. VICP

0001493152-23-028151

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 14, 2023 32.64M sh
Short Term Debt Q2 2023 · Jun 30, 2023 $54.23K
Cash And Equivalents Q2 2023 · Jun 30, 2023 $231.28K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $14.1K
Current Liabilities Q2 2023 · Jun 30, 2023 $1.47M
Current Liabilities Q2 2023 · Dec 31, 2022 $1.02M
Current Assets Q2 2023 · Jun 30, 2023 $378.15K
Current Assets Q2 2023 · Dec 31, 2022 $72.02K
Total Assets Q2 2023 · Jun 30, 2023 $378.15K
Total Assets Q2 2023 · Dec 31, 2022 $72.02K
Shares Diluted Q2 2023 · Jun 30, 2022 31.19M sh
Shares Diluted Q2 2023 · Jun 30, 2022 29.96M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$200.01K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$466.59K
Stockholders Equity Q2 2023 · Mar 31, 2022 −$287.62K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$121.65K
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.01
Eps Basic Q2 2023 · Jun 30, 2022 −$0.01
Eps Basic Q2 2023 · Jun 30, 2022 −$0.01
Sga Expense Q2 2023 · Jun 30, 2022 $16.16K
Sga Expense Q2 2023 · Jun 30, 2022 $28.95K
Rd Expense Q2 2023 · Jun 30, 2022 $10K
Net Income Q2 2023 · Jun 30, 2022 −$180.06K
Net Income Q2 2023 · Jun 30, 2022 −$347.1K
Net Income Q2 2023 · Mar 31, 2022 −$167.05K
Operating Income Q2 2023 · Jun 30, 2022 −$180.06K
Operating Income Q2 2023 · Jun 30, 2022 −$347.1K